2 active not recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
Follow Ribitol: new trials by email Literature Review of Ribitol trials Research Report on Ribitol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9 BBP-418 (ribitol) - Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) | Phase 3 | Active not recruiting | ML Bio Solutions, Inc. | 107 | 2026-06-05 | 2026-07-02 |
| Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) BBP-418 (ribitol), Placebo - Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) | Phase 3 | Active not recruiting | ML Bio Solutions, Inc. | 112 | 2023-05-31 | 2026-09-09 |
Muscular Dystrophy, Limb-Girdle, Type 2I (2)
Australia (2) · Denmark (2) · Germany (2) · Italy (2) · Netherlands (2) · Norway (2) · United Kingdom (2) · United States (2)